ACR Provides Input to FDA on AI Measurement and Evaluation
ACR submitted comments to FDA on real-world AI device performance, stressing safety, governance, and continuous monitoring.
Read moreThe National Institutes of Health (NIH) Office of Research on Women’s Health and several of the NIH institutes and centers issued a Notice of Special Interest (NOSI) to highlight interest in receiving research applications focused on diseases and health conditions that: predominantly affect women; present and progress differently in women; or are female specific. The release of the NOIS is in coordination with White House Executive Order to Advance Women’s Health Research and Innovation, part of the Biden administration’s White House Initiative on Women’s Health Research. The NOSI expires Nov. 5, 2027.
NOSI applications should have a central focus on the health of women, as demonstrated through specific aims that either explicitly address a particular condition in women or focus on one of the high-priority topics. Several of the highlighted topics of interest to imaging include:
For more information, contact Katie Grady, ACR Government Affairs Director.
ACR Provides Input to FDA on AI Measurement and Evaluation
ACR submitted comments to FDA on real-world AI device performance, stressing safety, governance, and continuous monitoring.
Read moreRadiology’s Fight Against Prior Authorization Delays
ACR is leading national efforts to make prior authorization more efficient and clinically appropriate while reducing the administrative burden and supporting national legislation.
Read moreACR Supports Medicaid Coverage of Lung Cancer Screening
ACR-backed bill would mandate Medicaid lung cancer screening, expand cessation coverage, ban prior auth—aiming to save lives and reduce disparities.
Read more